EuroHYP-1 - support from ZOLL Medical Corporation

ZOLL Medical is a member of the European Stroke Reseach Network for Hypothermia ( Through this membership and commitment towards hypothermia research, ZOLL Medical supports the EuroHYP-1 trial with the provision of the Thermogard XP, CoolGard 3000 Temperature Management Systems (at a preferential price); and also training delivered to the investigators participating in the EuroHYP-1 trial.

This support enables the implementation of the EuroHYP-1 trial via facilitating the access to the cooling equipment and the expertise required to deliver with success this complex treatment.

Thermogard XP, CoolGard 3000 Temperature Management System

The Zoll IVTM system is an endovascular cooling system that consists of a control module (either CoolGard 3000 or Thermogard XP), a CoolGard start-up kit, an ICY catheter (either IC-3585 AE or IC-3585 CO or IC-3893 AE or IC-3893 CO), a catheter convenience kit for catheter insertion (CO models only), thermal probes and cables.

The ICY catheters, in combination with the CoolGard 3000 or Thermogard XP control module, permit circulation of temperature-controlled saline through a heat exchanger to cool and re-warm the patient's blood in patients for whom the risks of a central line are warranted.

ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit

Contact data

ZOLL Medical Deutschland GmbH
Emil-Hoffmann Str. 13
50996 Cologne
+ 49 2236 87 87 - 413 Telephone
+ 49 2236 87 87 - 78 Fax
email: contact


EuroHYP-1 contactSteffen Stegherr, contact